ABSTRACT:
At present, thyroid-related disorders are increasing worldwide. In particular, hypothyroidism, which occurs when thyroid hormone levels fall below normal values, is one of the most frequently observed health problems among the population. Its main clinical manifestations include weight gain, fatigue, general weakness, chronic constipation, memory impairment, and cold intolerance. If hypothyroidism is not properly treated, it may lead to various metabolic disorders, such as diabetes mellitus and cardiovascular diseases. Although significant progress has been made in identifying the causes of hypothyroidism, understanding its clinical consequences, as well as in its diagnosis and treatment, a number of unanswered questions regarding its management still remain. Hypothyroidism is usually treated with synthetic pharmacological agents. However, long-term use of these drugs may cause adverse effects, including cardiac dysfunction, left ventricular hypertrophy, and oxidative stress–related liver damage1. Therefore, the development of new therapeutic approaches with no or fewer side effects that can improve thyroid function and alleviate hypothyroidism-induced pathophysiological processes in the body is of great importance. Plant-based preparations are often considered promising alternatives, as they usually have minimal or no adverse effects and provide valuable therapeutic potential for various metabolic disorders. This review aims to summarize the role of the thyroid gland and its hormones, the systemic changes observed in hypothyroidism, as well as the modulatory effects of polyphenols on thyroid function and hypothyroidism-associated metabolic syndromes.
Cite this article:
Mamadaliyeva Shohista Raviljon Qizi, Karimova Iroda Ibrohimjonovna, Yusupova Umidaxon Raxmonovna. Pathophysiological Processes Associated with Hypothyroidism and the Protective role of Polyphenols: Current Insights. Research Journal Pharmacy and Technology. 2026;19(9):4241-2. doi: 10.52711/0974-360X.2026.00592
Cite(Electronic):
Mamadaliyeva Shohista Raviljon Qizi, Karimova Iroda Ibrohimjonovna, Yusupova Umidaxon Raxmonovna. Pathophysiological Processes Associated with Hypothyroidism and the Protective role of Polyphenols: Current Insights. Research Journal Pharmacy and Technology. 2026;19(9):4241-2. doi: 10.52711/0974-360X.2026.00592 Available on: https://rjptonline.org/AbstractView.aspx?PID=2026-19-9-38
REFERENCES:
1. Anand K, Durgesh M, Sagarika B, Debolina Ch, Thomas E, Sunanda P. Phytochemical profiling of polyphenols and thyroid stimulatory activity of Ficus religiosa leaf extract in 6-propyl-thiouracil-induced hypothyroid rats. J Ethnopharmacol. 2023; 313: 116479. doi: https://doi.org/10.1016/j.jep.2023.116479
2. Хамнуева ЛЮ, Андреева ЛС, Хантакова ЕА. Йоддефицитные заболевания и синдром гипотиреоза: этиология, патогенез, диагностика, лечение. Иркутск: ИГМУ; 2018.
3. Janelle MCH. Back to the basics: thyroid gland structure, function and pathology. Clin Lab Sci. 2013; 26(2): 112-7.
4. Brent GA. Mechanisms of thyroid hormone action. J Clin Invest. 2012;122(9):3035-43. doi:10.1172/JCI60047.
5. Leko MB, Gunjača I, Pleško N, Zemunik T. Environmental factors affecting thyroid-stimulating hormone and thyroid hormone levels. Int J Mol Sci. 2021; 22(12): 6521. doi:10.3390/ijms22126521.
6. Bianco AC, Kim BW. Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest. 2006; 116(10): 2571-9.
7. Hoermann R, Midgley JEM, Larisch R, Dietrich JW. Relational stability in the expression of normality, variation, and control of thyroid function. Front Endocrinol (Lausanne). 2016; 7: 142.
8. Nappi A, Murolo M, Cicatiello AG, Sagliocchi S, Di Cicco E, Raia M, et al. Thyroid hormone receptor isoforms alpha and beta play convergent roles in muscle physiology and metabolic regulation. Metabolites. 2022; 12(5): 405. doi:10.3390/metabo12050405.
9. Zimmermann MB. Iodine deficiency. Endocr Rev. 2009;30(4):376-408.
10. Tuccari G, Vita R, Leni A. Thyroid gland: anatomy and physiology. In: Encyclopedia of Endocrine Diseases. 2nd ed. 2018. p. 382-90. doi:10.1016/B978-0-12-801238-3.96022-7.
11. Nilsson M, Fagman H. Development of the thyroid gland. Development. 2017; 144: 2123-40. doi:10.1242/dev.145615.
12. Singh S, Sandhu S. Thyroid disease and pregnancy. Treasure Island (FL): StatPearls Publishing; 2023.
13. Dentice M, Marsili A, Zavacki A, Larsen PR, Salvatore D. The deiodinases and the control of intracellular thyroid hormone signaling during cellular differentiation. Biochim Biophys Acta. 2013; 1830: 3937-45.
14. Mamadaliyeva SRQ, Abdulladjanova NG, Raimova KV, Rakhimov RN, Makhmudov RR, Yusupova UR. Effects of several polyphenols on some hematological and weight parameters in rats with experimental hypothyroidism. Trends Sci. 2025; 22(10): 10531. doi: https://doi.org/10.48048/tis.2025.10531
15. Luongo C, Dentice M, Salvatore D. Deiodinases and their intricate role in thyroid hormone homeostasis. Nat Rev Endocrinol. 2019; 15: 479-88. doi:10.1038/s41574-019-0218-2.
16. Hidemi O, Masahiro S. Dual oxidase, hydrogen peroxide and thyroid diseases. Exp Biol Med. 2010; 235: 424–433. doi: https://doi.org/10.1258/ebm.2009.009241
17. Ildiko S, Marc P, Maria M. H2O2 metabolism in normal thyroid cells and in thyroid tumorigenesis: focus on NADPH oxidases. Antioxidants. 2019; 8: 126. doi: https://doi.org/10.3390/antiox8050126
18. Крюков ЕВ, Стремоухов АА, Потехин НП, Чернавский СВ, Борисов АГ. Гипотиреоз: современные принципы диагностики и лечения. М.: РМАНПО; 2020
19. Aniruddh M, Thenmozhi MS. Correlation between thyroid function and obesity. Res J Pharm Technol. 2016; 9(10): 1568–1570.
20. Sadek SH, Khalifa WA, Azoz AM. Pulmonary consequences of hypothyroidism. Ann Thorac Med. 2017; 12: 204-8.
21. Velasco I, Bath SC, Rayman MP. Iodine as essential nutrient during the first 1000 days of life. Nutrients. 2018; 10(3): 290. doi:10.3390/nu10030290.
22. Opazo MC, González PA, Flores BD, Venegas LF, Albornoz EA, Kalergis AM, et al. Gestational hypothyroxinemia imprints a switch in the capacity of astrocytes and microglial cells of the offspring to react in inflammation. Mol Neurobiol. 2017; 54: 4373-87. doi:10.1007/s12035-017-0627-y.
23. Jenishia M. Thyroid disorders during pregnancy. Int J Nurs Educ Res. 2020;8(3):391–393. doi: https://doi.org/10.5958/2454-2660.2020.00084.8
24. Ahmed OM, El-Gareib AW, El-Bakry AM, Abd El-Tawab SM, Ahmed RG. Thyroid hormone states and brain development interactions. Int J Dev Neurosci. 2008; 26(7): 825-31. doi:10.1016/j.ijdevneu.2007.09.011.
25. Horn S, Heuer H. Thyroid hormone action during brain development: more questions than answers. Mol Cell Endocrinol. 2010; 315: 19-26. doi:10.1016/j.mce.2009.09.008.
26. Nunez J, Celi FS, Forrest D. Multigenic control of thyroid hormone functions in the nervous system. Mol Cell Endocrinol. 2008; 287: 1-12. doi:10.1016/j.mce.2008.03.006.
27. Williams GR. Neurodevelopmental and neurophysiological actions of thyroid hormone. J Neuroendocrinol. 2008; 20: 784-94. doi:10.1111/j.1365-2826.2008.01733.x.
28. Hayashida R, Rakugi H. Cognitive dysfunction in hypothyroidism. Sci Insights. 2023; 42(2). doi:10.15354/si.23.re126.
29. Zucchi R, Accorroni A, Chiellini G. Update on 3-iodothyronamine and its neurological and metabolic actions. Front Physiol. 2014; 5: 402. doi:10.3389/fphys.2014.00402.
30. Ceballos A, Belinchon MM, Sanchez-Mendoza E, Grijota-Martinez C, Dumitrescu AM, Refetoff S, et al. Importance of monocarboxylate transporter 8 for the blood-brain barrier-dependent availability of 3,5,3'-triiodo-L-thyronine. Endocrinology. 2009; 150(5): 2491-6. doi:10.1210/en.2008-1616.
31. Miller GM. The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity. J Neurochem. 2011; 116(2): 164-76. doi:10.1111/j.1471-4159.2010.07109.x.
32. Dinter J, Mühlhaus J, Wienchol CL, Yi CX, Nürnberg D, Morin S, et al. Inverse agonistic action of 3-iodothyronamine at the human trace amine-associated receptor 5. PLoS One. 2015; 10(2): e0117774. doi:10.1371/journal.pone.0117774.
33. Valcana T, Einstein ER, Csejtey J, Dalal KB, Timiras PS. Influence of thyroid hormones on myelin proteins in the developing rat brain. J Neurol Sci. 1975; 25(1): 19-27. doi:10.1016/0022-510X(75)90183-5.
34. Akintola AA, Jansen SW, van Bodegom D, van der Grond J, Westendorp RG, de Craen AJ, et al. Subclinical hypothyroidism and cognitive function in people over 60 years: a systematic review and meta-analysis. Front Aging Neurosci. 2015; 7: 150. doi:10.3389/fnagi.2015.00150.
35. Waliszewska-Prosół M, Ejma M. Hashimoto encephalopathy-still more questions than answers. Cells. 2022; 11(18): 2873. doi:10.3390/cells11182873.
36. Bégin ME, Langlois MF, Lorrain D, Cunnane SC. Thyroid function and cognition during aging. Curr Gerontol Geriatr Res. 2008; 2008: 474868. doi:10.1155/2008/474868.
37. Jabbar A, Pingitore A, Pearce SH, Zaman A, Iervasi G, Razvi S. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017; 14: 39-55.
38. Zúñiga D, Balasubramanian S, Mehmood KT, et al. Hypothyroidism and cardiovascular disease: a review. Cureus. 2024; 16(1): e52512. doi:10.7759/cureus.52512.
39. Biondi B, Klein I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine. 2004; 24: 1-13. doi:10.1385/ENDO:24:1:001.
40. Dardano A, Caraccio N, Monzani F. Evaluation of endothelial function in subclinical thyroid dysfunction. Thyroid. 2006; 16: 200-1. doi:10.1089/thy.2006.16.
41. Razvi S, Jabbar A, Pingitore A, et al. Thyroid hormones and cardiovascular function and diseases. J Am Coll Cardiol. 2018; 71: 1781-96. doi:10.1016/j.jacc.2018.02.045.
42. Udovcic M, Pena RH, Patham B, Tabatabai L, Kansara A. Hypothyroidism and the heart. Methodist Debakey Cardiovasc J. 2017; 13: 55-9. doi:10.14797/mdcj-13-2-55.
43. Delitala AP, Fanciulli G, Maioli M, Delitala G. Subclinical hypothyroidism, lipid metabolism and cardiovascular disease. Eur J Intern Med. 2017; 38: 17-24.
44. Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007; 116(15): 1725-35. doi:10.1161/CIRCULATIONAHA.106.678326.
45. McQuade C, Skugor M, Brennan DM, Hoar B, Stevenson C, Hoogwerf BJ. Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS database study. Thyroid. 2011; 21(8). doi:10.1089/thy.2010.0298.
46. Anandkumar S, Jessly Ch, Theertha CK, Usha M. Thyroid disorder: an overview. Res J Pharmacol Pharmacodyn. 2020; 12(1): 1–4. doi: https://doi.org/10.5958/2321-5836.2020.00001.4
47. Akha O, Kashi Z, Poor AS, Zadeh ZT, Zakeri HR. Evaluation of levothyroxine effect on pulmonary function in hypothyroidism. J Mazandaran Univ Med Sci. 2008; 18(67): 1-6.
48. Cohen B, Cadesky A, Jaggi S. Dermatologic manifestations of thyroid disease: a literature review. Front Endocrinol (Lausanne). 2023; 14: 1167890. doi: https://doi.org/10.3389/fendo.2023.1167890
49. Safer JD. Thyroid hormone action on skin. Dermato-Endocrinology. 2011; 3(3): 211–215. doi: https://doi.org/10.4161/derm.17027
50. Webb A, Li A, Kaur P. Location and phenotype of human adult keratinocyte stem cells of the skin. Differentiation. 2004; 72(8): 387–395. doi: https://doi.org/10.1111/j.1432-0436.2004.0720800
51. Shaker RN, Younis NT. Biochemical study on anti thyroid peroxidase antibody enzyme in serum blood of women with thyroid disease. Res J Pharm Technol. 2023; 16(1): 205–208. doi: https://doi.org/10.52711/0974-360X.2023.00038
52. Deborah FT, Adedipe FA. Effects of hypothyroidism and exogenous thyroxine on gastrointestinal organs of rat. Niger J Physiol Sci. 2016; 30(1–2): 59–64. doi: https://doi.org/10.4314/njps.v30i1-2
53. Basu G, Mohapatra A. Interactions between thyroid disorders and kidney disease. Indian J Endocrinol Metab. 2012; 16(2): 204–213. doi: https://doi.org/10.4103/2230-8210.93737
54. Schmitt R, Klussmann E, Kahl T, Ellison DH, Bachmann S. Renal expression of sodium transporters and aquaporin-2 in hypothyroid rats. Am J Physiol Renal Physiol. 2003; 284(5): F1097–F1104. doi: https://doi.org/10.1152/ajprenal.00368.2002
55. Yoko N, Peter S, Connie MR. The interplay between thyroid dysfunction and kidney disease. Semin Nephrol. 2021; 41(2): 133–143. doi: https://doi.org/10.1016/j.semnephrol.2021.03.008
56. Mariani LH, Berns JS. The renal manifestations of thyroid disease. J Am Soc Nephrol. 2012; 23(1): 22–26. doi: https://doi.org/10.1681/ASN.2010070766
57. Dhivya S, Gangopadhyay S, Pradeep Kumar S, Sarkar G. Serum creatinine and eGFR are affected in female hypothyroid patients with poor thyroid control. Asian J Pharm Tech. 2020; 10(4): 241–244.
58. Bingtao R, Yan Z. A new perspective on thyroid hormones: crosstalk with reproductive hormones in females. Int J Mol Sci. 2022;23:2708. doi: https://doi.org/10.3390/ijms23052708
59. De Stefano MA, Ambrosio R, Porcelli T, et al. Thyroid hormone action in muscle atrophy. Metabolites. 2021; 11(11): 730. doi: https://doi.org/10.3390/metabo11110730
60. Salvatore D, Simonides WS, Dentice M, Zavacki AM, Larsen PR. Thyroid hormones and skeletal muscle—new insights and potential implications. Nat Rev Endocrinol. 2014; 10(4): 206–214. doi: https://doi.org/10.1038/nrendo.2013.238
61. Bloise FF, Cordeiro A, Ortiga-Carvalho TM. Role of thyroid hormone in skeletal muscle physiology. J Endocrinol. 2018; 236(1): R57–R68. doi: https://doi.org/10.1530/JOE-16-0611
62. Macvanin MT, Gluvic Z, Zafirovic S, Gao X, Essack M, Isenovic ER. The protective role of nutritional antioxidants against oxidative stress in thyroid disorders. Front Endocrinol. 2023; 13: 1092837. doi: https://doi.org/10.3389/fendo.2022.1092837
63. Christina T, Panos GZ, Dionysios VC, Cédric OR, Gerasimos PS. The Keap1/Nrf2 signaling pathway in the thyroid—2020 update. Antioxidants. 2020; 9: 1082. doi: https://doi.org/10.3390/antiox9111082
64. Santos LR, Duraes C, Ziros PG, Pestana A, Esteves C, Neves C, et al. Interaction of genetic variations in NFE2L2 and SELENOS modulates the risk of Hashimoto’s thyroiditis. Thyroid. 2019;29:1302–1315.
65. Santos LR, Duraes C, Mendes A, Prazeres H, Alvelos MI, Moreira CS, et al. A polymorphism in the promoter region of the selenoprotein S gene (SEPS1) contributes to Hashimoto’s thyroiditis susceptibility. J Clin Endocrinol Metab. 2014; 99: 719–723.
66. Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol. 2015; 4: 180–183. doi: https://doi.org/10.1016/j.redox.2015.01.002
67. Mancini A, Di Segni C. Thyroid hormones, oxidative stress, and inflammation. Mediators Inflamm. 2016; 2016: 6757154. doi: https://doi.org/10.1155/2016/6757154
68. Makarewicz M, Drożdż I, Tarko T, Duda-Chodak A. The interactions between polyphenols and microorganisms, especially gut microbiota. Antioxidants. 2021; 10(2): 188. doi: https://doi.org/10.3390/antiox10020188
69. Mao X, Xiao X, Chen D, Yu B, He J. Tea and its components prevent cancer: a review of the redox-related mechanism. Int J Mol Sci. 2019; 20(21): 5249. doi: https://doi.org/10.3390/ijms20215249
70. Arjun S, Rupendra K. An overview on ethnopharmacological, phytochemical, and clinical significance of selected dietary polyphenols. Asian J Res Chem. 2023; 16(1): 8–12. doi: https://doi.org/10.52711/0974-4150.2023.00002
71. Tsao R. Chemistry and biochemistry of dietary polyphenols. Nutrients. 2010; 2(12): 1231–1246. doi: https://doi.org/10.3390/nu2121231
72. Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev. 2009; 2(5): 270–278. doi: https://doi.org/10.4161/oxim.2.5.9498
73. Duda-Chodak A, Tarko T. Possible side effects of polyphenols and their interactions with medicines. Molecules. 2023; 28(6): 2536. doi: https://doi.org/10.3390/molecules28062536
74. Ciumărnean L, Milaciu MV, Runcan O, et al. The effects of flavonoids in cardiovascular diseases. Molecules. 2020;25:4320. doi: https://doi.org/10.3390/molecules25184320
75. Petko A, Tsakovska I, Pajeva I. Computational studies of free radical-scavenging properties of phenolic compounds. Curr Top Med Chem. 2015; 15: 85–104.
76. Patel R, Rinker L, Peng J, Chilian WM. Reactive oxygen species: the good and the bad. In: Filip C, Albu E, editors. Reactive Oxygen Species (ROS) in Living Cells. Rijeka: IntechOpen; 2018. p. 7–20.
77. Kuchkarova LS, Kayumov KY, Ergashev NA, Kudeshova GT. Effect of quercetin on the intestinal carbohydrases activity in the offspring of the lead intoxicated mother. J Nat Remedies. 2024; 24(2): 391–396. doi: https://doi.org/10.18311/jnr/2024/32682
78. Vona R, Pallotta L, Cappelletti M, Severi C, Matarrese P. The impact of oxidative stress in human pathology: focus on gastrointestinal disorders. Antioxidants. 2021; 10(2): 201. doi: https://doi.org/10.3390/antiox10020201
79. Santi A, Baldissareli J, Murussi CR, Dias GRM, de Menezes CC, Zanini D, et al. Effects of quercetin on oxidative stress biomarkers in methimazole-induced hypothyroid rats. Exp Clin Endocrinol Diabetes. 2014; 122: 533–539. doi: https://doi.org/10.1055/s-0034-1376968
80. Alan M. Antioxidant flavonoids: structure, function, and clinical usage. Altern Med Rev. 2016; 1(2): 103–111.
81. Grimsrud PA, Xie H, Griffin TJ, et al. Oxidative stress and covalent modification of protein with bioactive aldehydes. J Biol Chem. 2008; 283: 21837–21841. doi: https://doi.org/10.1074/jbc.R700019200
82. Kale MK, Bhusari KP, Umathe SN. Relationship between the dynamics of oxidative stress and thyroid state. Res J Pharm Technol. 2008;1(1):14–17.
83. Khasan YK, Lubov SK, Jakhongir SA, Rashidbek KA, Shoaib K, Teodoro DT, et al. Impact of select polyphenols on α-amylase activity under in vitro conditions. Res J Pharm Technol. 2026; 19(1): 7–8. doi: https://doi.org/10.52711/0974-360X.2026.00002
84. Ritu S, Madan LK, Shradha B. Alpinia galanga (L) extracts decreases TSH levels and balances tri-iodothyronine (T3), thyroxine (T4) levels with protective effect on thyroid tissue in Wistar rats with thyroid disorder. Res J Pharm Technol. 2022; 15(10): 4372–4376. doi: https://doi.org/10.52711/0974-360X.2022.00733
85. Peeyush K, Saket SCh, Neelima Y, Aayush V, Manali R. Red grape seed extract for memory enhancement in Alzheimer’s disease in rats with reference to the glutamate metabolism. Res J Pharmacol Pharmacodyn. 2025; 17(4): 243–251. doi: https://doi.org/10.52711/2321-5836.2025.00039
86. Kalavakunda V, Subramanian I, Sorimuthu PS. Effect of zinc-3 hydroxyflavone complex on carbohydrate metabolic enzymes in hepatic and renal tissues of streptozotocin induced experimental diabetes in rats. Asian J Res Chem. 2012; 5(3): 345–350.
87. Jena S, Chainy GBN, Dandapat J. Expression of antioxidant genes in renal cortex of PTU-induced hypothyroid rats: effect of vitamin E and curcumin. Mol Biol Rep. 2012;39:1193–1203. doi: https://doi.org/10.1007/s11033-011-0849-4
88. Gayibov U, Gayibova SN, Pozilov MK, Tuxtaeva FS, Yusupova UR, Djabbarova GMK, et al. Influence of quercetin and dihydroquercetin on some functional parameters of rat liver mitochondria. J Microbiol Biotechnol Food Sci. 2021; 11(1): e2924. doi: https://doi.org/10.15414/jmbfs.2924
89. de Souza Dos Santos MC, Goncalves CF, Vaisman M, et al. Impact of flavonoids on thyroid function. Food Chem Toxicol. 2011; 49: 2495–2502. doi: https://doi.org/10.1016/j.fct.2011.06.074
90. Goncalves CFL, de Freitas ML, Ferreira ACF. Flavonoids, thyroid iodide uptake and thyroid cancer—a review. Int J Mol Sci. 2017; 18: 1247. doi: https://doi.org/10.3390/ijms18061247